Verastem | VSTM - 운영 비용





운영 비용 변화 날짜
AbbVie USD 10.27B 1000K 2026-06
Alaunos Therapeutics USD 1.01M 175K 2026-03
AstraZeneca USD 12.22B 4.04B 2026-06
Curis USD 11.52M 2.5M 2026-03
Cytokinetics USD 207.8M 7.22M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
Incyte USD 973.64M 4.65B 2026-06
Laboratory Of America USD 3.27B 146.9M 2026-06
Novartis USD 10.2B 912M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06
Verastem USD 63.57M 4.56M 2026-03